Call Today: (888) 277-7509
Submit your Nuvaring claim details for a free, no obligation case review
Get Started:
NuvaRing's pulmonary embolism risk is well established. Because of its ingredient etonogestrel, a metabolite of a synthetic hormone (desogestrel), there is a significantly higher risk of a NuvaRing blood clot occuring in a user compared to older contraceptives such as the Pill that don't contain desogestrel.
This increased blood clot risk from NuvaRing use — confirmed in more than a dozen clinical studies — increases the chance of a NuvaRing pulmonary embolism, which is the sudden blockage (i.e., embolism) of the blood's flow to one or both lungs (i.e., the pulmonary system). If a blood clot is large enough to stop the flow of blood to a lung, the potential outcomes include:
In most cases, a pulmonary embolism occurs when a blood clot forms in the leg and travels to the lungs. A clot in a deep vein (deep vein thrombosis, or DVT) can easily lead to a pulmonary embolism. The use of this contraceptive is also linked to an increased risk of NuvaRing deep vein thrombosis.
Any woman who is using a NuvaRing — and the other individuals in her environment — should be aware of the symptoms and signs of a pulmonary embolism. Any set of these is cause for medical attention:
If you have suffered a pulmonary embolism after using a NuvaRing, or if your loved one died due to a NuvaRing injury, contact us today to schedule a private, no-cost consultation with a NuvaRing attorney experienced in handling NuvaRing lawsuits. Our attorneys will fight to ensure you received the compensation you need and deserve.
U.S. District Judge Rodney Sipple announced that he elected to use the defendants’ proposed Plaintiff’s Fact Sheet when filing NuvaRing MDL lawsuits. The fact sheet requ...
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice